HEMOPHILIA B

Clinical trials for HEMOPHILIA B explained in plain language.

Never miss a new study

Get alerted when new HEMOPHILIA B trials appear

Sign up with your email to follow new studies for HEMOPHILIA B, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Trials to join now! 19 Not yet recruiting 4 Not yet finished but already full! 10 Completed 12 Terminated 1

Gene-Edited cells aim to stop bleeding in severe hemophilia b

Disease control Terminated

This early-stage trial tests a one-time treatment called BE-101 for adults with severe hemophilia B. The therapy uses a person's own blood cells, modified with CRISPR gene editing, to continuously produce the missing clotting factor. The goal is to reduce or prevent bleeding epis…

Matched conditions: HEMOPHILIA B

Phase: PHASE1, PHASE2 • Sponsor: Be Biopharma • Aim: Disease control

Last updated Jun 27, 2026 14:00 UTC

HEMOPHILIA B

Get alerted when new HEMOPHILIA B trials appear

Gene-Edited cells aim to stop bleeding in severe hemophilia b